Interstrand DNA crosslinking induced by anthracyclines in tumour cells
- 1 June 1994
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 47 (12) , 2269-2278
- https://doi.org/10.1016/0006-2952(94)90265-8
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Determination of covalent binding to intact DNA, RNA, and oligonucleotides by intercalating anticancer drugs using high-performance liquid chromatography. Studies with doxorubicin and NADPH cytochrome P-450 reductaseAnalytical Biochemistry, 1991
- The mode of action of cytotoxic and antitumor 1-nitroacridines. III. In vivo interstrand cross-linking of DNA of mammalian or bacterial cells by 1-nitroacridinesChemico-Biological Interactions, 1983
- The mode of action of cytotoxic and antitumor 1-nitroacridines. I. The 1-nitroacridines do not exert their cytotoxic effects by physicochemical binding with DNAChemico-Biological Interactions, 1983
- Adriamycin and daunomycin induce interstrand DNA crosslinks in HeLa S3 cellsBiochemical and Biophysical Research Communications, 1983
- Role of one-electron and two-electron reduction products of adriamycin and daunomycin in deoxyribonucleic acid bindingBiochemical Pharmacology, 1981
- Binding of [14C]-adriamycin to cellular macromolecules in vivoBiochemical Pharmacology, 1980
- Binding specificity of chemically and enzymatically activated anthracycline anticancer agents to nucleic acidsChemico-Biological Interactions, 1980
- Binding mode of chemically activated semiquinone free radicals from quinone anticancer agents to DNAChemico-Biological Interactions, 1979
- In vitro binding of metabolically activated [14C]-Ledakrin, or 1-nitro-9-14C-(3′-dimethylamino-n-propylamino) acridine, a new antitumor and DNA cross-linking agent, to macromolecules of subcellular fractions isolated from rat liver and HeLa cellsBiochemical Pharmacology, 1979
- Bioactivation as a Model for Drug Design Bioreductive AlkylationScience, 1977